Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL.
Hartert KT, Wenzl K, Krull JE, Manske M, Sarangi V, Asmann Y, Larson MC, Maurer MJ, Slager S, Macon WR, King RL, Feldman AL, Gandhi AK, Link BK, Habermann TM, Yang ZZ, Ansell SM, Cerhan JR, Witzig TE, Nowakowski GS, Novak AJ. Hartert KT, et al. Among authors: wenzl k. Leukemia. 2021 Feb;35(2):522-533. doi: 10.1038/s41375-020-0766-4. Epub 2020 Mar 5. Leukemia. 2021. PMID: 32139889 Free PMC article. Clinical Trial.
Whole-exome analysis reveals novel somatic genomic alterations associated with cell of origin in diffuse large B-cell lymphoma.
Manso BA, Wenzl K, Asmann YW, Maurer MJ, Manske M, Yang ZZ, Slager SL, Nowakowski GS, Ansell SM, Witzig TE, Feldman AL, Rimsza L, Link B, Cerhan JR, Novak AJ. Manso BA, et al. Among authors: wenzl k. Blood Cancer J. 2017 Apr 21;7(4):e553. doi: 10.1038/bcj.2017.33. Blood Cancer J. 2017. PMID: 28430174 Free PMC article. No abstract available.
Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma.
Wenzl K, Manske MK, Sarangi V, Asmann YW, Greipp PT, Schoon HR, Braggio E, Maurer MJ, Feldman AL, Witzig TE, Slager SL, Ansell SM, Cerhan JR, Novak AJ. Wenzl K, et al. Blood Cancer J. 2018 Oct 9;8(10):97. doi: 10.1038/s41408-018-0130-3. Blood Cancer J. 2018. PMID: 30301877 Free PMC article.
Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma.
Wu X, Stenson M, Abeykoon J, Nowakowski K, Zhang L, Lawson J, Wellik L, Li Y, Krull J, Wenzl K, Novak AJ, Ansell SM, Bishop GA, Billadeau DD, Peng KW, Giles F, Schmitt DM, Witzig TE. Wu X, et al. Among authors: wenzl k. Blood. 2019 Jul 25;134(4):363-373. doi: 10.1182/blood.2018874560. Epub 2019 May 17. Blood. 2019. PMID: 31101621 Free PMC article.
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
Wang Y, Wenzl K, Manske MK, Asmann YW, Sarangi V, Greipp PT, Krull JE, Hartert K, He R, Feldman AL, Maurer MJ, Slager SL, Nowakowski GS, Habermann TM, Witzig TE, Link BK, Ansell SM, Cerhan JR, Novak AJ. Wang Y, et al. Among authors: wenzl k. Blood Cancer J. 2019 Aug 30;9(9):73. doi: 10.1038/s41408-019-0233-5. Blood Cancer J. 2019. PMID: 31471540 Free PMC article.
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.
Krull JE, Wenzl K, Hartert KT, Manske MK, Sarangi V, Maurer MJ, Larson MC, Nowakowski GS, Ansell SM, McPhail E, Habermann TM, Link BK, King RL, Cerhan JR, Novak AJ. Krull JE, et al. Among authors: wenzl k. Blood Cancer J. 2020 Nov 9;10(11):117. doi: 10.1038/s41408-020-00382-3. Blood Cancer J. 2020. PMID: 33168821 Free PMC article. Clinical Trial.
The significance of gradient expression of chromosome region maintenance protein 1 (exportin1) in large cell lymphoma.
Abeykoon JP, Hampel PJ, King RL, Wood AJ, Larson MC, Nowakowski KE, Zanwar SS, Dasari S, Ruan GJ, Ravindran A, Wellik LE, Paludo J, Link BK, Cerhan JR, Ansell SM, Nowakowski GS, Thompson CA, Maurer MJ, Wenzl K, Novak AJ, Wu X, Habermann TM, Witzig TE. Abeykoon JP, et al. Among authors: wenzl k. Haematologica. 2021 Aug 1;106(8):2261-2264. doi: 10.3324/haematol.2020.278277. Haematologica. 2021. PMID: 33657788 Free PMC article. No abstract available.
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas.
Hopper MA, Wenzl K, Hartert KT, Krull JE, Dropik AR, Novak JP, Manske MK, Serres MR, Sarangi V, Larson MC, Maurer MJ, Yang ZZ, Paludo J, McPhail ED, Habermann TM, Link BK, Rimsza LM, Ansell SM, Cerhan JR, Jevremovic D, Novak AJ. Hopper MA, et al. Among authors: wenzl k. Hematol Oncol. 2023 Oct;41(4):644-654. doi: 10.1002/hon.3187. Epub 2023 May 30. Hematol Oncol. 2023. PMID: 37254453 Free PMC article.
33 results